Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Herrmann

Showing results (551-560 of 721) with videos related to

Pageof 73
Sort By:
The Lancet. Oncology|August 19, 2007
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialFlorian Lordick, Katja Ott, Bernd-Joachim Krause, et al.
Cancers|June 10, 2023
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on PrognosisNika Guberina, Florian Padeberg, Christoph Pöttgen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2024
Utility of pre-procedural [<sup>99m</sup>Tc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of <sup>90</sup>Y Glass microspheres in patients with Hepatocellular Carcinoma: comparison of anatomic versus [<sup>99m</sup>Tc]TcMAA-based SegmentationMarnix Lam, Etienne Garin, Paul Haste, et al.
Theranostics|May 23, 2017
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple MyelomaConstantin Lapa, Ken Herrmann, Andreas Schirbel, et al.
Immunotherapy|July 13, 2022
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factorsMaja Guberina, Nika Guberina, Christoph Pöttgen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PETFrancesco Ceci, Daniela E Oprea-Lager, Louise Emmett, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 11, 2022
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centreKen Herrmann, Luca Giovanella, Andrea Santos, et al.
Clinical Nuclear Medicine|December 22, 2020
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast CancerJanna Morawitz, Julian Kirchner, Ole Martin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial CarcinomaEmil Novruzov, Eduards Mamlins, Liam Widjaja, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2025
Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and Their Prognostic Value in Radical ProstatectomyAlexandros Moraitis, Theresa Kahl, Jens Kandziora, et al.
Pageof 73

Showing results (551-560 of 721) with videos related to

Sort By:
Pageof 73
The Lancet. Oncology|August 19, 2007
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trialFlorian Lordick, Katja Ott, Bernd-Joachim Krause, et al.
Cancers|June 10, 2023
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on PrognosisNika Guberina, Florian Padeberg, Christoph Pöttgen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 27, 2024
Utility of pre-procedural [<sup>99m</sup>Tc]TcMAA SPECT/CT Multicompartment Dosimetry for Treatment Planning of <sup>90</sup>Y Glass microspheres in patients with Hepatocellular Carcinoma: comparison of anatomic versus [<sup>99m</sup>Tc]TcMAA-based SegmentationMarnix Lam, Etienne Garin, Paul Haste, et al.
Theranostics|May 23, 2017
CXCR4-directed endoradiotherapy induces high response rates in extramedullary relapsed Multiple MyelomaConstantin Lapa, Ken Herrmann, Andreas Schirbel, et al.
Immunotherapy|July 13, 2022
Effectiveness of durvalumab consolidation in stage III non-small-cell lung cancer: focus on treatment selection and prognostic factorsMaja Guberina, Nika Guberina, Christoph Pöttgen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 19, 2021
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PETFrancesco Ceci, Daniela E Oprea-Lager, Louise Emmett, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 11, 2022
Joint EANM, SNMMI and IAEA enabling guide: how to set up a theranostics centreKen Herrmann, Luca Giovanella, Andrea Santos, et al.
Clinical Nuclear Medicine|December 22, 2020
Prospective Correlation of Prognostic Immunohistochemical Markers With SUV and ADC Derived From Dedicated Hybrid Breast 18F-FDG PET/MRI in Women With Newly Diagnosed Breast CancerJanna Morawitz, Julian Kirchner, Ole Martin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 19, 2026
Reliability and Practicability of FAP-RADS Version 1.0 for Structured Reporting of FAPI Imaging in Pulmonary and Urothelial CarcinomaEmil Novruzov, Eduards Mamlins, Liam Widjaja, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2025
Evaluation of Surgical Margins with Intraoperative PSMA PET/CT and Their Prognostic Value in Radical ProstatectomyAlexandros Moraitis, Theresa Kahl, Jens Kandziora, et al.
Pageof 73